Medical Device Advertising To Be Regulated
This article was originally published in PharmAsia News
China's State FDA is soliciting public comments on a recently prepared draft of medical device advertising censorship. Companies found advertising misleading information and fraudulent claims of products will have to publish corrections in the same media, and face sales suspension. All future advertisements of medical devices that include the product name, application, performance, structure, mechanism and other features, will need to be examined by provincial monitoring departments before given an approval number. Transgressors will not be allowed to apply to the censorship board for advertisements for up to one year. The deadline for feedback is Jan. 25, 2008. (Click here for more)
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.